{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:00:17Z","timestamp":1789390817160,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.leukres.2017.03.006","type":"journal-article","created":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T20:33:48Z","timestamp":1489005228000},"page":"85-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Haptoglobin is frequently low in patients with myelofibrosis: Clinical relevance"],"prefix":"10.1016","volume":"57","author":[{"given":"Paolo","family":"Strati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Masarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithviraj","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naval","family":"Daver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Pemmaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srdan","family":"Verstovsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.leukres.2017.03.006_bib0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/j.1460-2075.1985.tb02325.x","article-title":"Structure and expression of the human haptoglobin locus","volume":"4","author":"Bensi","year":"1985","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.leukres.2017.03.006_bib0010","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/blood.V40.6.875.875","article-title":"Primary and secondary myelofibrosis: its relationship to PNH-like defect","volume":"40","author":"Kuo","year":"1972","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2017.03.006_bib0015","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.3109\/10428194.2013.876628","article-title":"Paroxysmal nocturnal hemoglobinuria is not a cause of anemia in patients with myelofibrosis","volume":"55","author":"Nazha","year":"2014","journal-title":"Leuk. Lymphoma"},{"issue":"5","key":"10.1016\/j.leukres.2017.03.006_bib0020","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2017.03.006_bib0025","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2009-09-245837","article-title":"A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)","volume":"115","author":"Passamonti","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2017.03.006_bib0030","first-page":"647","article-title":"Biological functions of haptoglobin\u2013new pieces to an old puzzle","volume":"35","author":"Dobryszycka","year":"1997","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"issue":"3","key":"10.1016\/j.leukres.2017.03.006_bib0035","first-page":"255","article-title":"Primary myelofibrosis with positive coombs\u2019 test responding to prednisolone","volume":"37","author":"Yumoto","year":"1996","journal-title":"Rinsho Ketsueki"},{"issue":"10","key":"10.1016\/j.leukres.2017.03.006_bib0040","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.leukres.2014.08.007","article-title":"Clinical significance of microcytosis in patients with primary myelofibrosis","volume":"38","author":"Strati","year":"2014","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.leukres.2017.03.006_bib0045","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3324\/haematol.2016.148924","article-title":"A phase 1\/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis","volume":"102","author":"Gupta","year":"2016","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.leukres.2017.03.006_bib0050","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc2210","article-title":"Gilliland DG: role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders","volume":"7","author":"Levine","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.leukres.2017.03.006_bib0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/2040620710394474","article-title":"JAK2 allele burden in the myeloproliferative neoplasms: effects on phenotype, prognosis and change with treatment","volume":"2","author":"Vannucchi","year":"2011","journal-title":"Ther. Adv. Hematol."},{"issue":"6","key":"10.1016\/j.leukres.2017.03.006_bib0060","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood.V33.6.865.865","article-title":"Haptoglobin metabolism in polycythemia vera","volume":"33","author":"Krauss","year":"1969","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2017.03.006_bib0065","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3324\/haematol.2016.143644","article-title":"Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial","volume":"101","author":"Verstovsek","year":"2016","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.leukres.2017.03.006_bib0070","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.clml.2014.12.008","article-title":"Effects of ruxolitinib treatment on metabolic and nutritional parameters in patients with myelofibrosis from COMFORT-I","volume":"15","author":"Mesa","year":"2015","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"10","key":"10.1016\/j.leukres.2017.03.006_bib0075","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1517\/14656566.2014.923404","article-title":"Efficacy of ruxolitinib for myelofibrosis","volume":"15","author":"Santos","year":"2014","journal-title":"Expert Opin. Pharmacother."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617300826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617300826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T15:54:24Z","timestamp":1601740464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212617300826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":15,"alternative-id":["S0145212617300826"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.03.006","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Haptoglobin is frequently low in patients with myelofibrosis: Clinical relevance","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}